![[LSF] Life-Sciences-France.com - The French Life Sciences Web Portal](/images/basics/lsf-life-sciences-france-portal-logo.svg){kind=logo}
Advertisement
Persons > All
France
Monaco
Central France
Eastern France
Northern France
Paris (region)
Southern France
Western France
Find below all kinds of persons from France & Monaco.Total search results: 2420 | Ordered by Person (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 
  Person |
 Position |
Organisation (Group) |
Region |
|---|---|---|---|
| Schmitt-dos Santos, Juliette (Andrew Lloyd & Associates 2012– Director joined 2002) | Public Relations Manager / Investor Relations Manager | Andrew Lloyd & Associates (ALA) | Île-de-France (region) |
| Schmoll, Holger (AiCuris –2010–202212 CFO LEFT 12/22) | Chief Financial Officer (CFO) | STRÜNGMANN Group (family Strüngmann) | Nordrhein-Westfalen (federal state) |
| Schnee, Elmar (Cardiorentis 201110– CEO before Merck Serono S.A. 200701 CEO before Merck KGaA) | Chief Executive Officer (CEO) | Cardiorentis (Group) | Central Switzerland (region) |
| Schneider, Christian (Vesalius Biocapital 201006 Investment Manager before Polytechnos since 2001 before Centocor) | Investment Manager | Vesalius Biocapital (Group) | Luxembourg (cl=4) |
| Schneiderman, Daniel (Biophytis 201907 CFO) | Chief Financial Officer (CFO) | Biophytis (Group) | Île-de-France (region) |
| Schoreel, Anaïs (Eurasanté 201709 Business Development Manager) | Business Development Manager / Strategy Manager | GIE Eurasanté | Hauts-de-France (Upper France) (region) |
| Schottelius, Arndt (Kymab 201806 EVP RnD before MorphoSys 200812–201701 Chief Developm Officer before Genentech) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Sanofi (Group) [since May 2011] | East of England (region) |
| Schrenk, U. Marion (Servier 201604 Head Global Medical Strategy Oncology) | Corporate Strategy Manager | Servier (Group) | Île-de-France (region) |
| Schropp, Carola (EBD Group 201112 President) | President/Director/Head Business Group/Unit/Division | Informa (Group) [NEW] | California (federal state) |
| Schubert, Eric (Seismic Marketing 201811) | Public Relations Manager / Investor Relations Manager | Seismic Marketing LLC | New York (federal state) |
| Schueren, Robert (Arcturus 200502 COO) | Chief Operating Officer (COO) | Hologic (Group) | California (federal state) |
| Schuh, Antonius (Toni) (Global Source Ventures 202001 Managing Partner before Trovagene + AviaraDx/Arcturus + Sequenom) | Chief Executive Officer (CEO) | Trovagene Inc. | California (federal state) |
| Schur, Jonathan (Calliditas Therapeutics 202010– Group General Counsel before Goodwin Procter + Dechert) | General Counsel / Chief Legal Officer (CLO) | Calliditas Therapeutics (Group) | Stockholm (region) |
| Schwalm, Cynthia (Ipsen –201801 President of Ipsen North America LEFT 1/18) | Commercial Manager_o | Ipsen (Group) | New Jersey (federal state) |
| Schwarz, Otto (Actelion 201106– COO before Head Business Strategy + Operations since 2008) | Chief Operating Officer (COO) | Johnson & Johnson (JnJ) (Group) | Northwestern Switzerland (region) |
| Schweitzer, Gretchen (Trophic Comunications 201801 before MacDougall European Office) | Public Relations Manager / Investor Relations Manager | Trophic Communications GmbH | Bayern (federal state) |
| Schweitzer, Markus | n. a. | Sanofi (Group) [since May 2011] | Hessen (Hesse) (federal state) |
| Schweitzer, Nicolas (77 Foods 202201 CEO + Co-Founder) | Chief Executive Officer (CEO) | 77 Foods SAS (d/b/a La Vie Foods) | Île-de-France (region) |
| Schweizer, Liang (HiFiBio 201708– CEO + Co-Founder before Harbour BioMed + Sanofi Head of Asian Cancer Research) | Chief Executive Officer (CEO) | HiFiBio (Group) | Île-de-France (region) |
| Schwich, Pierre (Pharnext 201602– CFO before Cellectis + 3i + Siparex + Next Venture + Corning + Danone + HP) | Chief Financial Officer (CFO) | Pharnext SAS | Île-de-France (region) |
| Schüller, Wolfgang (Lipotec GmbH + Frankfurt BioTech Alliance e. V. before Aventis Research and Technologies 200205) | Managing Director | Sanofi (Group) [since May 2011] | Hessen (Hesse) (federal state) |
| Schächtele, Christoph (ProQinase 200805 CEO) | Chief Executive Officer (CEO) | Klinik für Tumorbiologie Freiburg (KTB) (Tumor Biology Center Freiburg) | Baden-Württemberg (federal state) |
| Scott, Robert A. (Cerenis 200801– CMO before AtheroGenics before Pifzer) | Chief Medical Officer (CMO) | Abionyx (Group) | Occitanie (Occitania) (region) |
| Scott, Ronald (Ron) (Basilea 201212–201804 CEO before COO before CFO RETIRED 2/18 proposed for Board) | Chief Executive Officer (CEO) | Basilea (Group) | Northwestern Switzerland (region) |
| Sèche, Edouard (VitamFero 201107 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | VitamFero S.A. | Île-de-France (region) |
| Sedel, Frédéric (MedDay 2011– CEO + Co-Founder) | Chief Executive Officer (CEO) | MedDay Pharmaceuticals SAS | Île-de-France (region) |
| Ségard, Lionel (Quantum Genomics 201707 CEO + Chairman) | Chief Executive Officer (CEO) | Quantum Genomics (FR) (Group) | Île-de-France (region) |
| Seghezzi, Graziano (Sofinnova Partners 200806 Partner) | Partner (venture partner) | Sofinnova (Group) | Île-de-France (region) |
| Séjourné, Florence (Boehringer 202210– CEO of Aurobac Therapeutics before Da Volterra + Genfit) | Chief Executive Officer (CEO) | Boehringer Ingelheim (Group) | Auvergne-Rhône-Alpes (region) |
| Sekhri, Paul J. (eGenesis 201901– CEO before Lycera + Sanofi + Teva + TPG Biotech + Cerimon + Ariad + Sprout) | Chief Executive Officer (CEO) | eGenesis (Group) | Massachusetts (federal state) |
| Selak, Sanya (Origimm Biotechnology 202112 CEO + CSO + Founder) | President/Director/Head Business Group/Unit/Division | Sanofi (Group) [since May 2011] | |
| Selig, Luc (Cellectis 201105 VP Sales + Marketing at Cellectis Bioresearch) | Sales Manager / Marketing Manager | Cellectis (Group) | Île-de-France (region) |
| Semerjian, Harout (Ipsen 201811 Chief Commerical Officer) | Chief Commercial Officer (CCO) | Ipsen (Group) | Île-de-France (region) |
| Senequier, Dominique (Adrian 201309 CEO) | Chief Executive Officer (CEO) | Ardian (Group) | Île-de-France (region) |
| Sergeant, Aurore (Mérieux 201602 Media Relations at bioMérieux) | Public Relations Manager / Investor Relations Manager | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Serra, Vincent (Wittycell 201402 CEO + CSO + Co-founder) | Chief Executive Officer (CEO) | Abivax (Group) | Grand Est (Great East) (region) |
| Serrano-Berntsen, Erik (Stable Asset Management 202207 CEO + Founder) | Chief Executive Officer (CEO) | Stable Asset Management | |
| Sesini, Frédéric (Servier 201601 EVP International Operations) | President/Director/Head Business Group/Unit/Division | Servier (Group) | Île-de-France (region) |
| Seta, Jean-Philippe (Servier 2003–201310 CEO joined Servier 1984 LEFT 201310) | Chief Executive Officer (CEO) | Servier (Group) | Île-de-France (region) |
| Shafer, Michael (Mike) (Thermo Fisher 201602 President Chemical Analysis) | President/Director/Head Business Group/Unit/Division | Thermo Fisher (Group) | Massachusetts (federal state) |
| Shangari, Nandita (RA Capital 202403 Managing Director at RA Capital Management before Novartis Venture Fund) | Investment Manager | RA Capital Management L.P. | Massachusetts (federal state) |
| Sharma, Ashwani (Eurosafe Sarl 201807 General Manager) | General Manager (management) | Eurosafe S.àr.l. | Bretagne (Britanny) (region) |
| Sharp, Dan (Valneva 202104 Government + Public Affairs Manager) | Public Relations Manager / Investor Relations Manager | Valneva (Group) | Pays de la Loire (region) |
| Shawver, Laura (Capstan Therapeutics 202403 CEO formerly Synthorx 201804 CEO) | Chief Executive Officer (CEO) | Sanofi (Group) [since May 2011] | California (federal state) |
| Shelton, Kathleen (Agilent 201207 Senior Director of Genomics Marketing) | Sales Manager / Marketing Manager | Agilent (Group) | California (federal state) |
| Shelver, Graham (908 Devices 201507– Commercial Leader before Scion Instruments + Bruker) | Chief Commercial Officer (CCO) | Bruker (Group) | |
| Sherif, Tarek (Medidata Solutions 201906 CEO + Co-Founder) | Chief Executive Officer (CEO) | Dassault Systèmes (3DS) (Group) | New York (federal state) |
| Shilo, Ori (Biond Biologics 202101 CFO + Co-Founder) | Chief Financial Officer (CFO) | Biond Biologics Ltd. | Israel_o |
| Shinseki, Matthew (Stern IR 201709) | Public Relations Manager / Investor Relations Manager | Precision Medicine Group (Group) | New York (federal state) |
| Shiver, John (Sanofi 201607 SVP RnD at Sanofi Pasteur before Merck US 200506) | President/Director/Head Business Group/Unit/Division | Sanofi (Group) [since May 2011] | |
| Shpichko, Olga (Russia (govt) 201202 Managing Director of Rusnano) | Managing Director | Russia (govt) | Moskow (region) |
| Shrotriya, Rajesh C. (200212 Spectrum Pharma CEO) | Chief Executive Officer (CEO) | Spectrum Pharmaceuticals (Group) | California (federal state) |
| Sibold, Bill (Sanofi 201801 EVP + Head of Sanofi Genzyme) | President/Director/Head Business Group/Unit/Division | Sanofi (Group) [since May 2011] | Massachusetts (federal state) |
| Siciliano, Nicholas (Invisible Sentinel 201902 CEO + Co-Founder) | Chief Executive Officer (CEO) | Mérieux (Group) | Pennsylvania (federal state) |
| Siddiqi, Naveed (Novo Ventures 201912– Partner before 201312– Partner at EdRIP BioDiscovery Funds + Phase4 Ventures) | Partner (venture partner) | Novo Group (Group) | Hovedstaden |
| Sidhoum, Marjorie (Domain Therapeutics 202205 Director of Business Development) | Business Development Manager / Strategy Manager | Domain Therapeutics (Group) | Grand Est (Great East) (region) |
| Sieler, Miguel (Neovacs 201310 CEO before Bayer France CEO at Bayer since 1975) | Chief Executive Officer (CEO) | Neovacs (Group) | Île-de-France (region) |
| Sierkstra, Laurens (BAC BV 200910 CEO) | Chief Executive Officer (CEO) | Thermo Fisher (Group) | North Holland (province, NL) |
| Silvente, Stéphane (Affichem 201508 CEO + Co-founder) | Chief Executive Officer (CEO) | Affichem (Group) | Occitanie (Occitania) (region) |
| Silverstein, Jordan (Immatics 202003 Head of Corporate Strategy before InflaRx + Advanced Accelerator Applications) | Business Development Manager / Strategy Manager | Immatics (Group) | Netherlands_o |
| Silvester, Peter (Life Technologies 201312 President EMEA) | President/Director/Head Business Group/Unit/Division | Thermo Fisher (Group) | California (federal state) |
| Simon, Crispin (Prothea Technologies 202404 CEO formerly President of Smith & Nephew endoscopy division) | Chief Executive Officer (CEO) | Prothea Technologies Ltd. | Scotland |
| Simon, Mathieu (Cellectis 2013–201803 COO joined 201204 as SVP Cellectis Group before Pierre Fabre + Wyeth RETIRED 3/18) | Chief Operating Officer (COO) | Cellectis (Group) | Île-de-France (region) |
| Simons, Frank (bioMérieux 200404 Global Product Manager Molecular Diagnostics) | Product Manager (personnel) | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Sin, Philip (HiFiBio 202106 CFO) | Chief Financial Officer (CFO) | HiFiBio (Group) | Massachusetts (federal state) |
| Sinclair, Mike (Halsin Partners 201110 Partner + Co-founder before Burns McClellan) | Public Relations Manager / Investor Relations Manager | Halsin Partners Ltd. | Greater London (region) |
| Singh, Amar (FMC 202107 Managing Director of FMC Ventures) | Managing Director | FMC (Group) | |
| Singh, Prahlad (PerkinElmer 201901– COO joined 2014 as President Diagnostics before GE Healthcare + Philips Healthcare) | Chief Operating Officer (COO) | PerkinElmer (Group) | Massachusetts (federal state) |
| Singhvi, Tushar (Crescent Enterprises 202306 Head of Investments) | Investment Manager | Crescent Enterprises (Group) | United Arab Emirates (UAE)_o |
| Sirat, Gabriel (Bioaxial 201311 CTO + Co-founder) | Chief Technology/Technical Officer (CTO) | Bioaxial SAS | Île-de-France (region) |
| Sirk, Kimberley (Cytel 202309 Senior Director Content + Communications) | Public Relations Manager / Investor Relations Manager | Cytel (Group) | Massachusetts (federal state) |
| Siviero, Paolo (Principia SGR 201801 Head of Investments) | Investment Manager | Principia SGR (Group) | Italy_o |
| Sixt, Bernhard (Edinburgh Molecular Imaging 201811– CEO before ImmunID + Agendia + Amersham + Nycomed) | Chief Executive Officer (CEO) | Edinburgh Molecular Imaging Ltd. (EM Imaging, EMI) | Scotland |
| Skerlj, Renato (AnorMed 200405) | n. a. | Sanofi (Group) [since May 2011] | British Columbia |
| Slack, Alex (Lauxera Capital Partners 202009 Founding Partner) | Partner (venture partner) | Lauxera (Group) | California (federal state) |
| Slaoui, Fatine (Alcen 202404 Head of Markeiting + Communications at Theryq) | Sales Manager / Marketing Manager | Alcen (Group) | France (region/state unspecified) |
| Slaoui, Moncef (GSK –201707 Chairman Vaccines TO RETIRE 6/17) | President/Director/Head Business Group/Unit/Division | GSK (Group) | United Kingdom (state/region unspecified) |
| Slump, John (Volta Medical 202301– CFO before Surgical Innovation Associates + Farapulse + Attune Medical) | Chief Financial Officer (CFO) | Volta Medical (Group) | Rhode Island (federal state) |
| Smith, Kevin (Micropep Technologies 202107 Board Chairman) | Board member, non-executive | Micropep Technologies SAS | Occitanie (Occitania) (region) |
| Smolentseva, Olga (Bryan Garnier 202110 Equity Research Analyst Biotechnology) | Analyst (Financial / Industry) | Bryan, Garnier (Group) | Île-de-France (region) |
| Solomon, David Horn (Mithra Pharmaceuticals 202304– before Pharnext+ Silence Tx + Zealand Pharma + Bionor Pharma) | Chief Executive Officer (CEO) | Mithra Pharmaceuticals (Group) | Wallonia (region) |
| Sordet, Nicolas (Afyren 202108 CEO + Co-Founder before Link Securities + BNP Paribas + Société Générale) | Chief Executive Officer (CEO) | Afyren (Group) | Auvergne-Rhône-Alpes (region) |
| Soriot, Pascal (AstraZeneca 201210– CEO before Roche COO Pharma Div before Genentech CEO) | Chief Executive Officer (CEO) | AstraZeneca (Group) | East of England (region) |
| Soroka, Joanna (Hitachi 202403 Principal at Hitachi Ventures GmbH) | Principal (venture capital) | Hitachi (Group) | Germany (state/region unspecified) |
| Sottil (before Filipowicz), Aneta (Andrea Partners 201804– before EdRIP before Norgine 2013 before Rothschild) | Investment Manager | Andera Partners (FR) | Île-de-France (region) |
| Sottilini, Frédéric (Carthera 202306 CEO) | Chief Executive Officer (CEO) | Carthera (Group) | Auvergne-Rhône-Alpes (region) |
| Soubeyran, Denis (France (govt) 201511– General Manager of LFB Biomedicaments joined 201009) | General Manager (management) | France (govt) | France (region/state unspecified) |
| Souêtre, Eric (Careventures 201011– Managing Partner + Labco 200904 CEO + Founder) | Chief Executive Officer (CEO) | Labco (Group) | France (region/state unspecified) |
| Soula, Gérard (Adocia 201201 CEO + co-founder also founder of Flamel Technologies) | Chief Executive Officer (CEO) | Adocia S.A. | Auvergne-Rhône-Alpes (region) |
| Soula, Olivier (Adocia 2005 co-founder) | Company Founder | Adocia S.A. | Auvergne-Rhône-Alpes (region) |
| Soula, Rémi (Argobio 202103– before Adocia + Avadel Pharmaceuticals) | Company Founder | Argobio SAS (BRIDGE collaboration) | Île-de-France (region) |
| Sourdive, David (Cellectis 200606 COO) | n. a. | Cellectis (Group) | Île-de-France (region) |
| Soustre, Jean-Marc (SE13 Advisors 202001 General Partner before 13advisory 201510 Partner) | Consultant (economic/technology) | SE13 Advisors S.a.r.l. Unipersonnelle | Provence-Alpes-Côte d’Azur (region) |
| Soyer, Eric (Erytech 201509– CFO + COO before EDAP-TMS) | Chief Financial Officer (CFO) | Erytech (Group) | Auvergne-Rhône-Alpes (region) |
| Spaggiari, Stefano (Expert System 201505 CEO) | Chief Executive Officer (CEO) | Expert System (Group) | Illinois (federal state) |
| Spagnol, Michel (Novasep 201306– CEO before Shasun + Rhodia) | Chief Executive Officer (CEO) | Novasep (Group) | Grand Est (Great East) (region) |
| Spagnol, Rémi (Supernova Invest 202306 Investment Director) | Investment Manager | CEA (Group) | Île-de-France (region) |
| Spedito-Jovial, Mélancolie (PathoQuest 202111 Marketing Manager) | Sales Manager / Marketing Manager | PathoQuest SAS | Île-de-France (region) |
| Speedie, Patrick (In-Part 202202 Co-CEO + Co-Founder) | Chief Executive Officer (CEO) | Inpart (Group) | Yorkshire and the Humber (region) |
| Spek, Hanspeter (sanofi-aventis 2007 Executive VP Pharmaceutical Operations) | n. a. | Sanofi (Group) [since May 2011] | Île-de-France (region) |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
